Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 12INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 687Breast Neoplasms 585Neoplasms 468Colorectal Neoplasms 300Prostatic Neoplasms 263Neoplasm Metastasis 257Melanoma 242Ovarian Neoplasms 228Recurrence 216Lung Neoplasms 203Multiple Myeloma 196Lymphoma, Non-Hodgkin 155Pancreatic Neoplasms 154Leukemia, Myeloid, Acute 142Carcinoma, Hepatocellular 141Stomach Neoplasms 137Lymphoma 131Carcinoma, Renal Cell 128Glioblastoma 118Squamous Cell Carcinoma of Head and Neck 113Head and Neck Neoplasms 113Lymphoma, Follicular 106Leukemia, Lymphocytic, Chronic, B-Cell 99Small Cell Lung Carcinoma 96Lymphoma, Large B-Cell, Diffuse 96Leukemia 96Brain Neoplasms 91Carcinoma 82Uterine Cervical Neoplasms 77Triple Negative Breast Neoplasms 73

Interventions

KRN 5500 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Neuralgia × Clear all
NCT06848348 2026-05-29

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Dogwood Therapeutics Inc.

Phase 2 Recruiting
240 enrolled
BreastGastrointestinal

Cancer Pain, Breast Neoplasms, Neoplasms, Neuralgia, Pain, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT00474916 2010-08-16

Neuropathic Pain in Patients With Cancer

DARA Therapeutics

Phase 2 Completed
19 enrolled

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡